Medicament for treating hyperosteogeny

Abstract

The invention discloses a medicament for treating hyperosteogeny. 21 grams of each of dry stems, leaves or roots of 24 medicinal materials of wild eucommia ulmoides vines, lygodium japonicum, schefflera arboricola vines, schefflera arboricola trees, paliurus hemsleyanus, caesalpinia cucullata, asiatic toddalia roots, ilexmacrocarpa oliv, wilson passionflower herbs, longtube groundIvy herbs, hypoglaucum schizophragma, laciniate blumea herbs, laciniate blumea stems, carex brownii tucker, passiflora henryi hemsl, champion bauhinia stems, smoothfruit ventilago roots and stems, rhizoma smilacis glabrae, moghania philippinensis, tylophora floribunda miq., cyrtomium fortune, blackberry lily, radix et caulis ventilaginis leiocarpae, fuchsia magellanica and the like are added with 2000 ml of local specially-prepared rice wine (with an alcoholic strength of about 30 degrees) and soaked for 96 hours to obtain the liquid which is the medicament. When in use, the prepared medicinal liquid can be orally taken by patients twice in the morning and in the evening, 21 ml for each time, and the medicinal liquid can be applied to hyperplastic parts of the patients with 12 days as a treatment course. For severe patients, the prepared medicinal liquid can be orally taken by patients for third times in the morning, at noon and in the evening, 21 ml for each time, and the medicinal liquid can be applied to hyperplastic parts of the patients to soften, eliminate, and cure the hyperplastic parts. One treatment course takes 12 days. The medicament of the invention has significant treatment effect after clinical practical application; hyperplastic parts of most patients are softened, eliminated and cured after the medicament is taken for 1-3 treatment courses, and no recurrence occurs.

Description

technical field [0001] The invention relates to the treatment of hyperosteogeny, in particular to a medicine for treating hyperosteogeny. Background technique [0002] Osteoarthritis, also known as proliferative osteoarthritis, osteoarthritis (OA), degenerative joint disease, senile arthritis, and hypertrophic arthritis, is due to the degeneration of soft tissues such as cartilage, intervertebral discs, and ligaments that make up the joints. Degeneration, the formation of bone spurs on the edge of the joint, hypertrophy of the synovium, and other changes, resulting in bone destruction, causing secondary bone hyperplasia, leading to joint deformation, and a disease that causes joint pain and limited mobility when subjected to abnormal loads . Bone hyperplasia is divided into two types: primary and secondary. Traditional Chinese medicine believes that the disease is related to trauma, strain, blood stasis blocking collaterals, feeling wind-cold dampness, internal resistance ...

AI Technical Summary

Problems solved by technology

Practice has proved that these treatment methods are not ideal, and all have limitations. They only treat the symptoms but not the root cause, and the disease is prone to relapse.